May 23, 2016

Bayer offers $62 billion for Monsanto

Washington Post

Bayer said said that it has offered to buy Monsanto for $62 billion in cash, potentially creating a giant agrochemicals company that would span genetically modified seeds and pesticides to antibiotics. Bayer, which is based in Germany, is probably best known as a pharmaceutical company with its iconic aspirin a staple of store shelves for more than 100 years. But it also has a long history in agriculture and said buying Missouri-based Monsanto would strengthen its hand in that market. Monsanto’s history as one of the first companies to create a genetically engineered seed has made it controversial.

No comments: